Literature DB >> 24805956

Overweight, adipocytokines and hypertension: a prospective population-based study.

Ekim Seven1, Lise L N Husemoen, Kristian Wachtell, Hans Ibsen, Allan Linneberg, Jørgen L Jeppesen.   

Abstract

OBJECTIVE: The adipocytokines, leptin, adiponectin, and interleukin-6, which stimulate liver C-reactive protein (CRP) production, are regarded as potential candidate intermediates between adipose tissue and overweight-induced hypertension.
METHODS: We examined the associations between leptin, adiponectin, and CRP levels with both prevalent and 5-year incident hypertension (IHT) in a general population of Danish adults (n = 5,868, 51.3% women, mean age 45.8 ± 7.9 years).
RESULTS: We recorded 2195 prevalent and 379 incident cases of hypertension. In models including leptin, CRP, adiponectin, sex, age, lifestyle risk factors, lipids, insulin, hemoglobin A1c, and in the incident model also baseline heart rate and blood pressure, only leptin of the three candidate intermediates was significantly associated with both prevalent and IHT [odds ratio (OR) = 1.18, 95% confidence interval (CI) 1.06-1.32, P = 0.002, and OR = 1.24, 95% CI 1.01-1.54, P = 0.044] for one standard deviation increase in log-transformed leptin levels, respectively. Log-transformed CRP was associated with prevalent (OR = 1.16, 95% CI 1.07-1.26, P < 0.001) but not IHT (OR = 0.98, 95% CI 0.84-1.14, P = 0.76). Log-transformed adiponectin was neither associated with prevalent nor IHT (OR = 0.94, 95% CI 0.87-1.02, P = 0.11 and OR = 0.93, 95% CI 0.80-1.08, P = 0.33). Comparing the lowest with the highest quintile of sex-specific BMI levels, there was an almost two-fold increase in IHT (OR = 1.89, 95% CI 1.10-3.25, P = 0.023) in the fully adjusted model. The population attributable risk estimate of IHT owing to overweight was 31%.
CONCLUSION: Leptin, but not adiponectin or CRP, may play a mediating role in overweight-induced hypertension. However, as BMI was a strong independent predictor of hypertension, other factors than leptin must be involved in the pathogenesis of overweight-related hypertension.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24805956     DOI: 10.1097/HJH.0000000000000207

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  15 in total

1.  Adiponectin resistance parameter as a marker for high normal blood pres-sure and hypertension in patients with metabolic syndrome.

Authors:  S Stojanovic; M Deljanin-Ilic; S Ilic; M Stefanovic; D Petrovic; V Petrovic; M Stojanovic
Journal:  Hippokratia       Date:  2020 Jan-Mar       Impact factor: 0.471

2.  Circulating Adipokines and Vascular Function: Cross-Sectional Associations in a Community-Based Cohort.

Authors:  Justin P Zachariah; Susan Hwang; Naomi M Hamburg; Emelia J Benjamin; Martin G Larson; Daniel Levy; Joseph A Vita; Lisa M Sullivan; Gary F Mitchell; Ramachandran S Vasan
Journal:  Hypertension       Date:  2015-11-30       Impact factor: 10.190

3.  Time Course of Blood Pressure Decrease After Bariatric Surgery in Normotensive and Hypertensive Patients.

Authors:  Devon N Hawkins; Byron J Faler; Yong U Choi; Balakrishna M Prasad
Journal:  Obes Surg       Date:  2018-07       Impact factor: 4.129

4.  Inflammation markers and risk of developing hypertension: a meta-analysis of cohort studies.

Authors:  Ahmad Jayedi; Kazem Rahimi; Leonelo E Bautista; Milad Nazarzadeh; Mahdieh Sadat Zargar; Sakineh Shab-Bidar
Journal:  Heart       Date:  2019-01-30       Impact factor: 5.994

5.  Adiponectin protects against incident hypertension independent of body fat distribution: observations from the Dallas Heart Study.

Authors:  Poghni A Peri-Okonny; Colby Ayers; Naim Maalouf; Sandeep R Das; James A de Lemos; Jarett D Berry; Aslan T Turer; Ian J Neeland; Philipp E Scherer; Wanpen Vongpatanasin
Journal:  Diabetes Metab Res Rev       Date:  2016-08-18       Impact factor: 4.876

6.  Biological Pathways in Adolescent Aortic Stiffness.

Authors:  Justin P Zachariah; Yunfei Wang; Jane W Newburger; Sarah D deFerranti; Gary F Mitchell; Ramachandran S Vasan
Journal:  J Am Heart Assoc       Date:  2021-03-01       Impact factor: 5.501

7.  Plasma Inflammatory Markers and the Risk of Developing Hypertension in Men.

Authors:  Howard D Sesso; Monik C Jiménez; Lu Wang; Paul M Ridker; Julie E Buring; J Michael Gaziano
Journal:  J Am Heart Assoc       Date:  2015-09-21       Impact factor: 5.501

8.  Adipocytokines, C-reactive protein, and cardiovascular disease: a population-based prospective study.

Authors:  Ekim Seven; Lise L N Husemoen; Thomas S G Sehested; Hans Ibsen; Kristian Wachtell; Allan Linneberg; Jørgen L Jeppesen
Journal:  PLoS One       Date:  2015-06-02       Impact factor: 3.240

9.  Higher serum concentrations of N-terminal pro-B-type natriuretic peptide associate with prevalent hypertension whereas lower associate with incident hypertension.

Authors:  Ekim Seven; Lise L N Husemoen; Hans Ibsen; Nele Friedrich; Matthias Nauck; Kristian Wachtell; Allan Linneberg; Jørgen L Jeppesen
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

10.  Associations of Whole Blood n-3 and n-6 Polyunsaturated Fatty Acids with Blood Pressure in Children and Adolescents - Results from the IDEFICS/I.Family Cohort.

Authors:  Maike Wolters; Valeria Pala; Paola Russo; Patrizia Risé; Luis A Moreno; Stefaan De Henauw; Kirsten Mehlig; Toomas Veidebaum; Denés Molnár; Michael Tornaritis; Claudio Galli; Wolfgang Ahrens; Claudia Börnhorst
Journal:  PLoS One       Date:  2016-11-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.